IMR Press / CEOG / Volume 19 / Issue 4 / pii/1634202876214-812851240

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Clinical and laboratory work-up prior to hormone replacement therapy in postmenopausal women
Show Less
1 Department of Obstetrics and Gynecology, Beilinson Medical Center, Petah-Tiqva, and Tel Aviv University, Medical School (Israel)
2 Women’s Health Center, Ghivatayim, Kupat Holim, (Israel)
Clin. Exp. Obstet. Gynecol. 1992, 19(4), 215–217;
Published: 10 December 1992

In a retrospective study on 100 female patients (mean age 52 years), with a menopause lasting for 3.5 years, referred to the Menopausal Clinic of Beilinson Medical Center, we studied the pretreatment, clinical and laboratory work-up before administration of hormone replacement therapy (HRT). The work-up consisted of clinical and medical examination and history. Mammography is a necessary test for malignancy exclusion, and also the assessment of lipid metabolism. Pap smear is not so important since cervical cancer is a rare event in Jewish women and pelvic sonography cannot be a decisive diagnostic tool for ruling out malignancy. We conclude that HRT for prevention of osteoporosis and cardiovascular disease should be administered in a menopausal clinic by a gynecologist, after performing a few tests: confirmation of menopause by follicle-stimulation hormone (FSH) and E2, excluding malignancy by mammography, and confirmation of normal lipid metabolism.
Hormone replacement therapy
Back to top